Diagnostics take centre stage at World Health Assembly
This article was originally published in Clinica
Cuba and Egypt are not accustomed to being cast on the world stage as developers of innovative diagnostics, but together with the likes of Brazil, China and India, they are at the centre of an international debate on how to improve the supply of key biomedical technology to meet the needs of so-called neglected diseases in developing countries.
You may also be interested in...
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.